Chalfont Centre for Epilepsy, Chalfont St Peter, Bucks, UK.
Department of Clinical & Experimental Epilepsy, UCL Queen Square Institute of Neurology, London, UK.
Epilepsia Open. 2024 Jun;9(3):1059-1066. doi: 10.1002/epi4.12940. Epub 2024 Apr 9.
To assess asymptomatic rates and severity of SARS-CoV-2 infection in people with epilepsy and their healthcare workers in a long-term care facility which had implemented weekly surveillance testing between April 2020 and June 2022.
Questionnaires focused on objective and subjective COVID-19 symptoms for people with epilepsy residing in and their healthcare workers at the Chalfont Centre for Epilepsy in June 2022. Demographic information, comorbidities, and seizure frequency were gathered from medical records. We also collected responses on objective and subjective COVID-19 symptoms from healthcare workers who participated in a prospective study assessing the reaction to COVID-19 vaccinations (SAFER).
Fifty-five out of 89 (62%) residents tested positive at least once on weekly PCR testing for SARS-CoV-2 during the period of interest; 20 of those (37%) were asymptomatic. In comparison, of those 63 healthcare workers who tested positive at least once on weekly testing during the same period, only four (6%) were asymptomatic. Of the 159 healthcare workers who also participated in the SAFER study, 41 tested positive at least once, and seven (17%) were completely asymptomatic during infection with SARS-CoV-2.
People with epilepsy living in a long-term care facility were more likely to present with asymptomatic SARS-CoV-2 infections than healthcare workers at the same facility. Despite possible bias in the reporting of subjective symptoms due to management-by-proxy, there is no evidence that vulnerable people living in an epilepsy long-term care facility showed reduced resilience towards infections.
People with epilepsy living in care home facilities had a surprisingly high degree of asymptomatic infections with SARS-CoV-2. Very few residents had severe or fatal outcomes. This is in stark contrast to the widely reported bad outcomes for people without epilepsy in other care homes. People with epilepsy reported significantly less symptoms than their healthcare workers. No changes in seizure frequency during or after infection were observed.
评估 2020 年 4 月至 2022 年 6 月期间在长期护理机构中每周进行监测检测的情况下,癫痫患者及其医护人员的无症状 SARS-CoV-2 感染率和严重程度。
2022 年 6 月,针对在 Chalfont 癫痫中心居住的癫痫患者及其医护人员,我们使用专门的调查问卷,重点评估了他们的 COVID-19 症状(客观和主观症状)。我们从病历中收集了人口统计学信息、合并症和癫痫发作频率。我们还收集了参与评估 COVID-19 疫苗接种反应(SAFER)的前瞻性研究的医护人员的客观和主观 COVID-19 症状的反馈。
在所关注的时间段内,每周进行的 SARS-CoV-2 PCR 检测中,89 名居民中有 55 名(62%)至少有一次检测结果为阳性;其中 20 名(37%)为无症状感染。相比之下,在同一时期每周检测结果至少为阳性一次的 63 名医护人员中,只有 4 名(6%)为无症状感染。在参与 SAFER 研究的 159 名医护人员中,41 名至少有一次检测结果为阳性,其中 7 名(17%)在感染 SARS-CoV-2 期间完全无症状。
在长期护理机构中生活的癫痫患者出现无症状 SARS-CoV-2 感染的可能性高于同一机构的医护人员。尽管由于代理管理,可能会对主观症状的报告存在偏差,但没有证据表明生活在癫痫长期护理机构的脆弱人群对感染的抵抗力降低。
居住在护理院的癫痫患者感染 SARS-CoV-2 后,出现无症状感染的比例高得惊人。很少有患者出现严重或致命的后果。这与其他护理院中未患癫痫的患者所报告的严重后果形成鲜明对比。癫痫患者报告的症状明显少于他们的医护人员。在感染期间或之后,癫痫发作频率没有变化。